Conditions: Peripheral Neuropathy
Keywords: QST (quantitative sensory testing) neuropathic pain tapentadol pr oxycodone
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 3
Healthy volunteers: no

Brief summary:
The purpose of this study is to elucidate whether the additional mechanism of analgesia, i.e. reuptake inhibition of norepinephrine, of tapentadol leads to a change in different pain signs and symptoms in comparison to oxycodone.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: tapentadol, oxycodone
Intervention descriptions: intervention 1: tapentadol pr 100-500 mg oxycodone cr 20-120mg

Protocol document: